COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology Vol. 75; no. 25; p. 3184
Main Author: Gollob, Michael H
Format: Journal Article
Language:English
Published: United States 30.06.2020
Subjects:
Betacoronavirus
Clinical Trials as Topic
Coronavirus Infections - prevention & control
COVID-19
Enzyme Inhibitors - therapeutic use
Humans
Hydroxychloroquine - therapeutic use
Long QT Syndrome - diagnosis
Long QT Syndrome - etiology
Long QT Syndrome - prevention & control
Pandemics - prevention & control
Patient Selection
Pneumonia, Viral - prevention & control
SARS-CoV-2
COVID-19
QT interval
clinical trials
genetics
sudden cardiac death
ISSN:1558-3597, 1558-3597
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1558-3597
1558-3597
DOI:10.1016/j.jacc.2020.05.008